‘Living drug’ offers hope to terminal blood cancer patients
NHS patients with lymphoma have for the first time been given a pioneering treatment that genetically reprogrammes their immune system to fight cancer. Mike Simpson, 62, from Durham, says his cancer is now “on the run”. The therapy, called CAR-T, is a “living drug” that is tailor-made for each patient using their body’s own cells… Read More »